Home Press Release Global Immuno Oncology Assays Market Driven by Emergence of Multi-Modal Biomarker Signatures Beyond PD-L1 and Expansion of Decentralized, Hybrid Clinical Trials

Global Immuno Oncology Assays Market Driven by Emergence of Multi-Modal Biomarker Signatures Beyond PD-L1 and Expansion of Decentralized, Hybrid Clinical Trials

16 Feb, 2026

Insights into Market Size, Trends, Market Dynamics, Key Segments, and Emerging Players

Straits Research, a leading market research organization, announced the release of the report titled “Immuno Oncology Assays Market Size and Outlook —Forecasts till 2034”. The report provides an in-depth analysis of the market size, trends, opportunities, and market mechanism. The report also covers a regional analysis of several market factors.

According to the report, the market is valued at USD 6.91 billion in 2026, which is expected to grow to USD 17.95 billion by 2034. The projected CAGR for this period is 12.66%.

The immuno oncology assays market is segmented based on product & services, technology, indication, application and region. Some of the insights provided in the report are highlighted below:

  • The consumables segment dominated the market with the largest share of 62.45% in 2025.
  • North America is expected to lead the immune oncology assays market during the forecast period, supported by a high concentration of oncology research activities, advanced diagnostic infrastructure, and widespread use of biomarker-driven testing.
  • Globally, healthcare and research institutions are shifting toward multiplex and precision immune oncology assays, driven by the need to accurately predict immunotherapy response, stratify patients using complex immune biomarkers, and support drug development pipelines through translational research and companion diagnostic workflows.
  • Germany is expected to lead the European market with its advanced pathology infrastructure and higher adoption of biomarker-driven and immune-guided treatment protocols.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market.

Market Segments

The contents of the report are as follows:

By Products & Services

  • Consumables
  • Instruments
  • Software & Services

By Technology

  • PCR
  • Immunoassay
  • NGS
  • ISH
  • Flow Cytometry

By Indication

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Bladder Cancer
  • Melanoma
  • Others

By Application

  • Research Applications
  • Clinical Diagnostics

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Want to see full report on
Immuno-Oncology Assays Market

Related Reports

WhatsApp
Chat with us on WhatsApp